Cancer Policy Institute Advisory Board
Adam R. Borden, MHA
Director of Policy and Reimbursement Strategy, Siemens Healthineers
Caroline Brown
Partner, Covington & Burling LLP
Daniel E. Smith, JD
Founder and President, AdvocacySmiths
David M. Fox, JD
Partner, Hogan Lovells
Deborah Kamin, RN, PhD
Vice President, Policy and Advocacy, American Society of Clinical Oncology
Diana D. Jeffery, PhD
Government Health Psychologist
Dylan H. Roby, PhD
Associate Professor & Associate Chair of Health Services Administration, University of Maryland School of Public Health
Eberechukwu Onukwugha, MS, PhD
Associate Professor, Department of Pharmaceutical Health Services Research (PHSR) University of Maryland School of Pharmacy
Fauzea Hussain
Vice President of Public Policy, McKesson
Greg Gierer
Senior Vice President for Policy America's Health Insurance Plans
Jeff Allen, PhD
President and Chief Executive Officer Friends of Cancer Research
Jeff Belkora, PhD
Associate Professor Institute for Health Policy Studies University of California, San Francisco
Jessica Banthin, PhD
Senior Fellow, The Urban Institute
Lauren G. Barnes
Board Chair, Cancer Support Community Vice President, Managed Markets Vertex Pharmaceuticals
Lisa Simms Booth
Executive Director, Smith Center for Healing and the Arts
Lisa Simpson, MB, BCh, MPH, FAAP
President and CEO, AcademyHealth
Lovell A. Jones, PhD, FHDR
Executive Director of the HDEART Consortium, Texas A&M School of Public Health
Michael Kolodziej, MD
Vice President and Chief Innovation Officer, ADVI Health
Michael Paese
Global Co-Lead, Office of Government Affairs, Goldman Sachs
Niraj Gupta, MD
Medical Director St. Vincent Cancer Care
Rujul Desai, JD
Counsel, Covington & Burling LLP
Sharyl J. Nass, PhD
Director National Cancer Policy Forum, National Academies of Sciences, Engineering, and Medicine
Stephen Edge, MD, FACS
Vice President of Healthcare Outcomes and Policy; Professor of Oncology, Roswell Park Cancer Institute